[EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
申请人:ASTRAZENECA AB
公开号:WO2019002442A1
公开(公告)日:2019-01-03
The specification relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.